Volume 69, Issue 9, Pages (May 2006)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 5, Pages (May 2004)
Advertisements

Volume 84, Issue 3, Pages (September 2013)
G1 kinases and transforming growth factor-β; signaling are associated with a growth pattern switch in diabetes-induced renal growth  Hai-Chang Huang,
Volume 66, Issue 1, Pages (July 2004)
Selenium-deficient diet induces renal oxidative stress and injury via TGF-β1 in normal and diabetic rats  Alluru S. Reddi, Jaya S. Bollineni  Kidney International 
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 85, Issue 2, Pages (January 2014)
Hui Ying Li, Yoon Sin Oh, Ji-Woong Choi, Ji Yong Jung, Hee-Sook Jun 
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Volume 78, Issue 4, Pages (August 2010)
Volume 70, Issue 4, Pages (August 2006)
Inhibition of cytochrome P450 2E1 and activation of transcription factor Nrf2 are renoprotective in myoglobinuric acute kidney injury  Zhe Wang, Sudhir.
Volume 85, Issue 2, Pages (January 2014)
MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Critical role for osteopontin in diabetic nephropathy
Volume 71, Issue 10, Pages (May 2007)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 78, Issue 9, Pages (November 2010)
Volume 83, Issue 5, Pages (May 2013)
L.-H. Weng, C.-J. Wang, J.-Y. Ko, Y.-C. Sun, Y.-S. Su, F.-S. Wang 
Volume 74, Issue 7, Pages (October 2008)
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Volume 73, Issue 5, Pages (March 2008)
Volume 67, Issue 4, Pages (April 2005)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 69, Issue 1, Pages (January 2006)
Volume 78, Issue 2, Pages (July 2010)
Volume 87, Issue 2, Pages (February 2015)
Volume 64, Issue 2, Pages (August 2003)
Volume 75, Issue 12, Pages (June 2009)
Volume 56, Issue 3, Pages (September 1999)
Volume 84, Issue 3, Pages (September 2013)
Volume 73, Issue 8, Pages (April 2008)
Volume 74, Issue 11, Pages (December 2008)
Volume 65, Issue 3, Pages (March 2004)
Volume 69, Issue 6, Pages (March 2006)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 70, Issue 9, Pages (November 2006)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 70, Issue 3, Pages (August 2006)
Volume 72, Issue 3, Pages (August 2007)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 62, Issue 1, Pages (July 2002)
Volume 58, Issue 4, Pages (October 2000)
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Volume 66, Issue 1, Pages (July 2004)
Volume 85, Issue 2, Pages (January 2014)
Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells  Z. Su, J. Zimpelmann, K.D. Burns  Kidney.
Volume 73, Issue 6, Pages (March 2008)
Volume 82, Issue 3, Pages (August 2012)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 59, Issue 3, Pages (March 2001)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 69, Issue 11, Pages (June 2006)
Volume 56, Pages S178-S181 (July 1999)
Volume 65, Issue 6, Pages (June 2004)
Volume 70, Issue 5, Pages (September 2006)
Prasun K. Datta, Elias A. Lianos  Kidney International 
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 55, Issue 2, Pages (February 1999)
Increased renal calcium and magnesium transporter abundance in streptozotocin- induced diabetes mellitus  C-T. Lee, Y-H.H. Lien, L-W. Lai, J-B. Chen, C-R.
Volume 72, Issue 11, Pages (December 2007)
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
Volume 21, Issue 2, Pages (February 2013)
Volume 72, Issue 2, Pages (July 2007)
Volume 55, Issue 4, Pages (April 1999)
Volume 70, Issue 1, Pages (July 2006)
Presentation transcript:

Volume 69, Issue 9, Pages 1593-1600 (May 2006) Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries  C.-L. Lin, F.-S. Wang, Y.-R. Kuo, Y.-T. Huang, H.-C. Huang, Y.-C. Sun, Y.-H. Kuo  Kidney International  Volume 69, Issue 9, Pages 1593-1600 (May 2006) DOI: 10.1038/sj.ki.5000329 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 High glucose and AGEs increased TGF-β1 and fibronectin mRNA expression of mesangial cells. Cells (1 × 106 cell/well, in six-well plate) were cultured in medium containing 35 mM D-glucose or 100 μg/ml AGEs for 8 days. The results graphed represent the relative abundance of the (a) TGF-β1 and (b) fibronectin gene by real-time PCR normalized to housekeeping gene β-actin. Experimental results are presented as means±s.e.'s calculated from six-paired triplicate experiments. Symbols: ▾, vehicle; •, high glucose-treated group; and, ○, AGE-treated group. Kidney International 2006 69, 1593-1600DOI: (10.1038/sj.ki.5000329) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Superoxide, but not hydrogen peroxide or nitric oxide, mediated high glucose- or AGE-enhanced TGF-β1 and fibronectin mRNA expression of mesangial cells. Cell cultures (1 × 106 cell/well, in six-well plate) were pretreated with 500 U/ml SOD-PEG or 500 U/ml catalase-PEG or 100 μMN-nitro-L-arginine methyl ester (L-NAME) and subjected to 35 mM D-glucose or 100 μg/ml AGE treatment for 2 days. The experimental results graphed represent the relative abundance of the TGF-β1 and fibronectin gene by real-time PCR normalized to housekeeping gene β-actin. Experimental results are presented as means±s.e.'s errors calculated from six-paired triplicate experiments. *, #, and + show differences (P<0.05) from the vehicle, high glucose-, and AGE-treated groups, respectively. Kidney International 2006 69, 1593-1600DOI: (10.1038/sj.ki.5000329) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 High glucose and AGEs increased superoxide synthesis by mesangial cells. (a) High glucose and AGEs rapidly increased superoxide synthesis in 1 h Inhibition of superoxide by DPI, but not by rotenone or allopurinol, reduced high glucose-augmented (b) superoxide production in 1 h, (c) TGF-β1, and (d) fibronectin mRNA expression in 2 days. Cell cultures (1 × 106 cells/well, in six-well plate) were pretreated with 20 μM DPI or 30 μM allopurinol or 30 μM rotenone and subjected to 35 mM D-glucose and 100 μg/ml AGE for 2 days. The graphed results represent the relative abundance of TGF-β1 and fibronectin genes by real-time PCR normalized to housekeeping gene β-actin. Experimental results are presented as means±s.e.'s calculated from six-paired triplicate experiments. *, #, and + show differences (P<0.05) from the vehicle, high glucose-, and AGE-treated groups, respectively. Kidney International 2006 69, 1593-1600DOI: (10.1038/sj.ki.5000329) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 High glucose or AGEs increased cytosolic ERK and nuclear c-Jun activation. High glucose and AGEs did increase (a) cytosolic ERK and (c) nuclear c-Jun activation but not evidently alter (b) p38 activation. Cytosolic and nuclear fractions of cell lysates from cell cultures with or without 35 mM glucose or 100 μg/ml AGE treatment were subjected to Western blot assay. Immunoblotting of cytosolic ERK, p38, and nuclear c-Jun showed equal loadings and transfer for all lanes. All blots represent at least three experiments, each with comparable results. Kidney International 2006 69, 1593-1600DOI: (10.1038/sj.ki.5000329) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 High glucose and AGEs rapidly increased Ras activation. (a) Inhibition of Ras activity by manumycin A reduced the promoting effect of high glucose and AGEs on (b) Ras activation and (c) superoxide synthesis in 1 h. Cell cultures (1 × 106 cells/well, in six-well plate) were pretreated with 10 μM manumycin A and subjected to high glucose or AGE treatment for 2 days. Experimental results are presented as means values±s.e.'s calculated from six-paired triplicate experiments. *, #, and + show differences (P<0.05) from the vehicle, high glucose-, and AGE-treated groups, respectively. Kidney International 2006 69, 1593-1600DOI: (10.1038/sj.ki.5000329) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 6 Pretreatment with SOD, DPI, PD98059, and manumycin A reduced the promoting effect of high glucose and AGEs on cytosolic ERK, nuclear c-Jun activation, TGF-β1, and fibronectin mRNA expression. (a, b) Cell cultures were pretreated with 500 U/ml SOD-PEG, 20 μM DPI, 10 μM PD98059, or 10 μM manumycin A, and then 35 mM glucose or 100 μg/ml AGE treatment. (c, d) The graphed results represent the relative abundance of TGF-β1 and fibronectin genes by real-time PCR normalized to housekeeping gene β-actin. Experimental results are presented as means±s.e.'s calculated from six-paired triplicate experiments. *, #, +, and @ show differences (P<0.05) from the vehicle, high glucose-, and AGE-treated groups, respectively. Immunoblotting of cytosolic ERK, p38, and nuclear c-Jun showed equal loadings and transfer for all lanes. All blots represent at least three experiments, each with comparable results. Kidney International 2006 69, 1593-1600DOI: (10.1038/sj.ki.5000329) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 7 Exogenous SOD abolished diabetic renal damages in rats. Exogenous SOD abolished the enhancing effect of diabetes on (a) systemic superoxide levels and (b) urinary albumin secretion in rats. (c) Exogenous SOD reduced the promoting effect of diabetes on TGF-β1, fibronectin, and 8-hydroxy-2′-deoxyguanosine levels in renal tissue. Diabetic rats received 50 U/kg/day SOD-PEG treatment for 28 days. Systemic superoxide synthesis was measured by SOD-inhibitable cytochrome c reduction of mononuclear cells harvested from peripheral blood. Albumin and creatinine levels in urine were assayed using their respective assay kits. Immunoblotting of actin showed equal loadings and transfer for all lanes. Experimental results are presented as means±s.e.'s calculated from eight rats. * and #, respectively, show differences from normal and DM-vehicle groups, P<0.05. Symbols: ○, control group; ▾, DM rats with vehicle treatment; and, ▿, DM rats with SOD-PEG treatment. Kidney International 2006 69, 1593-1600DOI: (10.1038/sj.ki.5000329) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 8 Immunohistochemical photograph of glomeruli in diabetic rats with or without SOD-PEG treatment. In comparison with the control group, mesangial cells at glomeruli in diabetic kidneys expressed stronger TGF-β1, fibronectin, and 8-hydroxy-2′-deoxyguanosine immunostaining. Decreased TGF-β1, fibronectin, and 8-hydroxy-2′-deoxyguanosine were observed in diabetic rats after SOD-PEG treatment. Positive TGF-β1, fibronectin, and 8-hydroxy-2′-deoxyguanosine immunostained cells showed brown color. Specimens were observed under original magnification × 400. Kidney International 2006 69, 1593-1600DOI: (10.1038/sj.ki.5000329) Copyright © 2006 International Society of Nephrology Terms and Conditions